Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

140.46
Delayed Data
As of 3:59pm ET
 +0.22 / +0.16%
Today’s Change
96.18
Today|||52-Week Range
149.34
+14.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash529.9M944.0M1.0B966.0M
 
 
 
 
 
Short Term Investment Cash-459.6M414.1M66.1M-44.0M
 
 
 
 
 
Cash & Short Term Investments1.5B2.0B1.4B1.3B
 
 
 
 
 
 
ReceivablesReceivables443.6M432.9M532.8M650.0M
 
 
 
 
 
 
InventoriesInventories102.6M176.4M289.9M375.0M
 
 
 
 
 
 
Current AssetsPrepaid Expenses49.2M------
 
 
Other Current Assets76.7M225.1M217.6M260.0M
 
 
 
 
 
Current Assets2.2B2.8B2.4B2.6B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross305.2M529.9M873.2M1.2B
 
 
 
 
 
Depreciation-104.1M-137.7M-176.1M-193.0M
 
 
 
 
 
Intangible Assets863.8M841.1M9.8B9.3B
 
 
 
 
 
Other Assets926.3M941.2M10.0B9.6B
 
 
 
 
 
Total Assets3.3B4.2B13.1B13.3B
 
 
 
 
 
 
LiabilitiesAccounts Payable21.6M44.0M57.4M64.0M
 
 
 
 
 
Short Term Debt48.0M48.0M175.0M167.0M
 
 
 
 
 
Accrued Expenses228.5M211.9M276.1M348.0M
 
 
 
 
 
Other Current Liabilities447.9M426.3M370.7M471.0M
 
 
 
 
 
Other Liabilities582.4M606.7M718.3M823.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt65.0M9.5M3.3B2.9B
 
 
 
 
 
Deferred Taxes-97.8M-27.9M-529.0M-396.0M
 
 
 
 
 
Other Liabilities48.0M53.1M224.7M323.0M
 
 
 
 
 
Total Liabilities935.6M899.9M4.9B4.6B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity2.4B3.3B8.3B8.7B
 
 
 
 
 
Total Shareholder Equity2.4B3.3B8.3B8.7B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding197.0M199.1M225.6M224.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.